SHPH'
s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0.66
Current: 0.66
During the past 6 years, Shuttle Pharmaceuticals Holdings's highest PB Ratio was 0.66. The lowest was 0.00. And the median was 0.00.
SHPH's PB Ratio is ranked better than 87.11% of 923
companies
in the Drug Manufacturers industry
Industry Median: 1.81
vs SHPH: 0.66
During the past 12 months, Shuttle Pharmaceuticals Holdings's average Book Value Per Share Growth Rate was -74.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -78.30% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Shuttle Pharmaceuticals Holdings was -78.30% per year. The lowest was -78.30% per year. And the median was -78.30% per year.
Back to Basics: PB Ratio
Shuttle Pharmaceuticals Holdings (NAS:SHPH) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Shuttle Pharmaceuticals Holdings PB Ratio Related Terms
Shuttle Pharmaceuticals Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shuttle Pharmaceuticals Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shuttle Pharmaceuticals Holdings PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shuttle Pharmaceuticals Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Shuttle Pharmaceuticals Holdings's PB Ratio falls into.
Shuttle Pharmaceuticals Holdings PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Shuttle Pharmaceuticals Holdings (SHPH) has a PB Ratio of 0.66 as of Jun. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shuttle Pharmaceuticals Holdings and its competitors. According to the industry distribution chart, Shuttle Pharmaceuticals Holdings ranks #119 out of 923 companies in the Drug Manufacturers industry, placing it in the top 12.9%.
Is Shuttle Pharmaceuticals Holdings' PB Ratio too high?
Shuttle Pharmaceuticals Holdings' current PB Ratio is 0.66. The Drug Manufacturers industry median PB Ratio is 1.81. Shuttle Pharmaceuticals Holdings' value of 0.66 is 63.5% below this industry median. Based on the distribution chart, Shuttle Pharmaceuticals Holdings ranks #119 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shuttle Pharmaceuticals Holdings has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Shuttle Pharmaceuticals Holdings' PB Ratio compare to PRFX and CBIH?
According to the Drug Manufacturers industry distribution chart, Shuttle Pharmaceuticals Holdings ranks #119 out of 923 companies for PB Ratio. This places Shuttle Pharmaceuticals Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.81. Shuttle Pharmaceuticals Holdings' value of 0.66 is 63.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.81, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shuttle Pharmaceuticals Holdings's current PB Ratio of 0.66 is 63.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shuttle Pharmaceuticals Holdings and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shuttle Pharmaceuticals Holdings's current PB Ratio is 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shuttle Pharmaceuticals Holdings stock overvalued right now?
Shuttle Pharmaceuticals Holdings (SHPH) has a current PB Ratio of 0.66. The current PB Ratio is 0.66 and 63.5% below the Drug Manufacturers industry median of 1.81. Shuttle Pharmaceuticals Holdings' overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Shuttle Pharmaceuticals Holdings (SHPH), the current PB Ratio is 0.66 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shuttle Pharmaceuticals Holdings Business Description
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
24GF Score
Get the complete analysis for SHPH
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHPH has been successfully added to your 
